← Back to Search

Other

Novel spectacle lens design for Progressive Myopia (CHERRY Trial)

N/A
Waitlist Available
Led By Lyndon Jones, PhD, FCOptom
Research Sponsored by SightGlass Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

CHERRY Trial Summary

This trial studied the choroid, a layer of tissue in the eye, & its role in near-sightedness.

Who is the study for?
This trial is for individuals already enrolled in the CPRO-1802-001 study who have near-sightedness, including degenerative or progressive myopia. Participants must be minors who've given their assent and whose parents or guardians have signed a consent letter. Those with temporary health issues affecting the eyes like colds, allergies, or fatigue cannot join.Check my eligibility
What is being tested?
The study is testing a new type of spectacle lens designed to control the progression of myopia by examining changes in choroidal thickness (a layer at the back of the eye) throughout the day.See study design
What are the potential side effects?
Since this trial involves wearing special glasses, side effects may include discomfort from wearing new lenses, potential headaches or eye strain during adaptation to lenses.

CHERRY Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Choroidal thickness
Secondary outcome measures
Visual field

CHERRY Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Subjects wearing novel spectacle lenses will be assessed
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Novel spectacle lens design
2022
N/A
~60

Find a Location

Who is running the clinical trial?

SightGlass Vision, Inc.Lead Sponsor
10 Previous Clinical Trials
1,083 Total Patients Enrolled
University of WaterlooOTHER
123 Previous Clinical Trials
209,771 Total Patients Enrolled
Lyndon Jones, PhD, FCOptomPrincipal InvestigatorCORE
11 Previous Clinical Trials
411 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the qualifications to participate in this trial?

"To participate in this study, children must have myopia and be between 6-10 years old. So far, 10 young patients have been enrolled."

Answered by AI

Are there any vacancies in this experiment for test subjects?

"The clinical trial mentioned is not currently seeking patients, as per the information available onclinicaltrials.gov. This particular study was posted on December 18th, 2018 and last updated November 3rd, 2022; however, there are 102 other trials that are actively recruiting right now."

Answered by AI

Is this research project available to adults over the age of fifty-five?

"This particular trial is only testing on children aged 6 to 10 years old. Out of the 83 total trials, 65 are for patients that are underage and 18 studies test on elderly patients."

Answered by AI
~2 spots leftby Mar 2025